Healthcare M&A up on Q4 2022
Healthcare is showing its resilience with rising deal volume in a challenging market. Find out how the sector started 2023 in M&A.
Investor interest in Pharma services keeps growing
As the pharmaceutical sector becomes even more complex, investor interest is turning to third-party companies.
R&D tax relief changes: are you due a check-up?
Staying ahead of reforms to research and development tax relief can help you ensure your claims comply.
